Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: Comparison of indirect prevalence estimation methods

Addiction

Volumn 103, Issue 10, 2008, Pages 1604-1613

  Kimber, Jo ^a,b   Hickman, Matthew ^a,c   Degenhardt, Louisa ^b   Coulson, Tim ^d   Van Beek, Ingrid ^e  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Sydney Medically Supervised Injecting Centre   (Australia)

Author keywords

Drug consumption rooms; Indirect prevalence estimation methods; Injecting drug use; Medical supervision

Indexed keywords

ARTICLE; AUSTRALIA; HEALTH CARE DELIVERY; HEALTH SURVEY; HUMAN; INTRAVENOUS DRUG ABUSE; MORTALITY; NEEDLE; PREDICTION; PREVALENCE; SYRINGE;

ADOLESCENT; ADULT; AUSTRALIA; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; POPULATION DYNAMICS; PREVALENCE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH;

EID: 51249104212     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02276.x     Document Type: Article

References (53)

1. Gibson A., Degenhardt L., Topp L. et al. Global and Australian Heroin Markets. Sydney:National Drug and Alcohol Research Centre 2002.
2. Van Beek I. The Sydney Medically Supervised Injecting Centre: a clinical model. J Drug Issues 2003 33:625 38.
3. Kimber J., Macdonald M., Van Beek I., Kaldor J., Weatherburn D., Lapsley H. et al. Sydney Medically Supervised Injecting Centre: client characteristics and predictors of frequent attendance in the first 12-months of operation. J Drug Issues 2003 33:639 49.
4. Habicht J., Victora C., Vaughan J. Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. Int J Epidemiol 1999 28:10 18.
5. Hickman M., Higgins V., Hope V., Bellis M., Tilling K., Walker A. et al. Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators. J Epidemiol Commun Health 2004 58:766 71.
6. Stimson G. V., Hickman M., Rhodes T., Bastos F., Saidel T. Methods for assessing HIV and HIV risk among IDUs and for evaluating interventions. Int J Drug Policy 2005 16:7 20.
7. Sharma M., Burrows D., Bluthenthal B. Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward. Int J Drug Policy 2007 18:92 8.
8. Hser Y.-I., Anglin M. D., Wickens T., Brecht M.-L., Homer J. Techniques for the Estimation of Illicit Drug-Use Prevalence: an Overview of Relevant Issues. New York:National Institute of Justice 1992.
9. Maxwell J. Methods for estimating the number of 'hard-core' drug users. Subst Use Misuse 2000 35:399 420.
10. Hook E. B., Regal R. R. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995 17:243 64.
11. Monitoring E., Addiction D. Scientific Review of the Literature on Estimating the Prevalence of Drug Misuse on the Local Level. Lisbon:European Monitoring Centre for Drugs and Drug Addiction 1999.
12. Hickman M., Taylor C. Indirect methods to estimate prevalence. In:Sloboda Z., editor. Epidemiology of Drug Abuse. New York:Springer US 2005 p. 113 31.
13. Brecht M.-L., Wickens T. Application of multiple capture methods for estimating drug use prevalence. J Drug Issues 1993 23:229 50.
14. Hickman M., Taylor C., Chatterjell A., Degenhardt L., Frischer M., Hay G. et al. Estimating the prevalence of problematic drug use: a review of methods and their application. Bull Narc 2002 LIV:15 32.
15. Hickman M., Cox S., Harvey J., Howes S., Farrell M., Frischer M. et al. Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. Addiction 1999 94:1653 62.
16. Frischer M., Leyland A., Cormack R., Goldberg D., Bloor M., Green S. et al. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Scotland. Am J Epidemiol 1993 138:170 81.
17. Hser Y.-I. Population estimation of illicit drug users in Los Angeles County. J Drug Issues 1993 23:323 34.
18. Choi K. H., Comiskey C. M. Methods for providing the first prevalence estimates of opiate use in Western Australia. Int J Drug Policy 2003 14:297 305.
19. Hay G., Smit F. Estimating the number of drug injectors from needle exchange data. Addict Res Theory 2003 11:235 43.
20. Seber G. A note on the multiple-recapture census model. Biometrika 1965 52:249 59.
21. Jolly G. M. Explicit estimates from capture-recapture data with both death and immigration-stochastic model. Biometrika 1965 52:225 47.
22. Mckeganey N., Barnard M., Leyland A., Coote I., Follet E. Female street-working prostitution and HIV infection in Glasgow. BMJ 1992 305:801 4.
23. Degenhardt L., Rendle V., Hall W., Gilmour S., Law M. Valid Methods of Estimating the Size of a Drug Using Population after a Marked Reduction in Drug Supply. Sydney:National Drug and Alcohol Research Centre 2004.
24. Frischer M. Estimating the prevalence of drug abuse using the mortality multiplier method: an overview. In:Stimson G. V., Hickman M., Quirk A., Frischer M., Taylor C., editors. Estimating the Prevalence of Problem Drug Use in Europe: Scientific Monograph No. 1. Lisbon:EMCDDA 1997, p. 113 26.
25. Global Assessment Programme on Drug Abuse. GAP Toolkit Module 2: Estimating Prevalence: Indirect Methods for Estimating the Size of the Drug Problem. Vienna:United Nations Office on Drugs and Crime 2003.
26. Degenhardt L., Adelstein B.-A., Darke S., Hodda A. Early Indicators of Trends in Opioid Overdose Deaths. Sydney:National Drug and Alcohol Research Centre, UNSW 2002.
27. Frischer M., Hickman M., Kraus L., Mariani F., Wiessing L. A comparison of different methods for estimating the prevalence of problematic drug abuse in Great Britain. Addiction 2001 96:1465 76.
28. Hartnoll R., Lewis R., Mitcheson M., Bryer S. Estimating the prevalence of opioid dependence. Lancet 1995 1:203 5.
29. Hall W., Ross J., Lynskey M., Law M., Degenhardt L. How many dependent opioid users are there in Australia? Med J Aust 2000 173:528 31.
30. Medically Supervised Injecting Centre (MSIC) Evaluation Committee. Final Report of the Evaluation of the Sydney Medically Supervised Injecting Centre. Sydney:University of New South Wales 2003.
31. Macdonald M., Zhou J. Prevalence of HIV, HCV and Injecting and Sexual Behaviour among IDU at Needle and Syringe Programs: Australian NSP Survey National Data Report 1995-2001. Sydney:National Centre for HIV Epidemiology and Clinical Research 2002.
32. Jauncey M., Taylor L., Degenhardt L. The definition of opioid-related deaths in Australia: implications for surveillance and policy. Drug Alcohol Rev 2005 24:401 9.
33. Degenhardt L., Roxburgh A. Accidental Drug-Induced Deaths Due to Opioids in Australia. Sydney:National Drug and Alcohol Research Centre.
34. Macdonald M. HIV and HCV Infection and Related Risk Behaviour among Injecting Drug Users at Selected Needle and Syringe Programs throughout Australia, 1995-1998. Sydney:National Centre in HIV Epidemiology and Clinical Research 2001.
35. Iverson J., Topp L., Maher L. Australian NSP Survey National Data Report, 2002-2006. Sydney:National Centre in HIV Epidemiology and Clinical Research 2007.
36. Australian Bureau of Statistics. Census Data 2001. Canberra:Australian Bureau of Statistics 2001.
37. Zelterman D. Robust estimation in truncated discrete distributions with applications to capture-recapture experiments. J Stat Plan Inference 1988 18:225 37.
38. Schwarz C. J., Arnason A. N. A general methodology for the analysis of open-model capture recapture experiments. Biometrics 1996 52:860 73.
39. Seber G. The Estimation of Animal Abundance and Related Parameters. London:Griffin 1982.
40. Jolly G. M. Mark-recapture models with parameters constant in time. Biometrics 1982 38:301 21.
41. White G. Program MARK. Fort Collins:Colorado State University 2004.
42. Degenhardt L., Conroy E., Gilmour S., Hall W. The effect of a reduction in heroin supply upon population trends in fatal and non-fatal drug overdoses. Med J Aust 2005 182:20 3.
43. Thein H. H., Maher L., Dore G. Australian NSP Survey: Prevalence of HIV, HCV and Injecting and Sexual Behaviour among IDUs at Needle and Syringe Programs, National Data Report 1999-2003. Sydney:National Centre for HIV Epidemiology and Clinical Research 2004.
44. Roxburgh A., Degenhardt L., Breen C., Barker B. New South Wales Drug Trends 2002: Findings from the Illicit Drug Reporting System (IDRS). Sydney:National Drug and Alcohol Research Centre 2003.
45. Day C., Degenhardt L., Gilmour S., Hall W. Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes. BMJ 2004 329:428 9.
46. Kehoe L., Hall W., Mant A. Estimates of the number of injecting drug users in a defined area. Aust J Public Health 1992 16:232 7.
47. Duque-Portugal F., Martin A., Taylor R., Ross M. Mark-recapture estimates of injecting drug users in Sydney. Aust J Public Health 1994 18:201 4.
48. Maher L., Dixon D., Lynskey M., Hall W. Running the Risks: Heroin, Health and Harm in South West Sydney. Sydney:National Drug and Alcohol Research Centre 1998.
49. Broadhead R. S., Kerr T. H., Grund J., Altice F. L. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues 2002 32:329 55.
50. Kimber J., Dolan K. Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia. J Urban Health 2007 84:255 66.
51. Van Beek I. Approaches to injecting drug use in Kings Cross: a review of the last 10 years. NSW Public Health Bull 2000 11:54 5.
52. Sweeting M. J., De Angelis D., Hickman M., Ades A. E. Estimating hepatitis C prevalence in England and Wales by synthesising evidence from multiple data sources. Assessing data conflict and model fit. Biometrica 2008 in press [Epub ahead of print].
53. MacDonald M., Wodak A., Ali R., Crofts N., Cunningham P., Dolan K. et al. HIV prevalence and risk behaviour in needle exchange attenders: a national study. Med J Aust 1997 166:237 40.